Title : ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia.

Pub. Date : 2022 Jun

PMID : 35462331






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Midostaurin, identified as an ABCB1 inhibitor, increased anthracycline accumulation in peripheral blood mononuclear cells (PBMC) of CD34+ AML patients and those not achieving CR. midostaurin CD34 molecule Homo sapiens
2 Overall, we highlight the therapeutic value of midostaurin as more than just a FLT3 inhibitor, suggesting its maximal therapeutic outcomes might be very sensitive to proper timing and well-optimized dosage schemes based upon patient"s characteristics, such as CD34 positivity and ABCB1 activity. midostaurin CD34 molecule Homo sapiens